Global Drug-Coated Balloons Market Trends, Growth, Top Key Players And Forecast To 2033

Overview and Scope

A drug-coated balloon (DCB) is a medical device used in the treatment of narrowed or blocked blood vessels, primarily in the field of interventional cardiology and interventional radiology. It is designed to deliver medication directly to the site of vascular disease while simultaneously performing angioplasty.

Sizing and Forecast

The drug-coated balloons market size has grown rapidly in recent years. It will grow from $0.95 billion in 2023 to $1.1 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%.  The growth in the historic period can be attributed to increased cardiovascular disease burden, demand for minimally invasive procedures, prevalence of peripheral artery disease (pad), reducing restenosis rates, advancements in interventional cardiology.

The drug-coated balloons market size is expected to see rapid growth in the next few years. It will grow to $1.93 billion in 2028 at a compound annual growth rate (CAGR) of 15.0%.  The growth in the forecast period can be attributed to increasing aging population, expansion of indications and applications, focus on outpatient and ambulatory care, integration with drug delivery innovations, global health initiatives. Major trends in the forecast period include regulatory approvals for new formulations, focus on minimizing side effects, emergence of bioresorbable coatings, market expansion in emerging economies, patient-centric approaches.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

Segmentation & Regional Insights

The drug-coated balloons market covered in this report is segmented –

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications

2) By Drug Type: Paclitaxel, Sirolimus

3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

North America was the largest region in the global drug-coated balloons market in 2023, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

Major Driver Impacting Market Growth

The rise in the prevalence of coronary artery disease is expected to propel the growth of the drug-coated balloons market going forward. Coronary artery disease (CAD) is a medical condition defined by the narrowing or obstruction of the coronary arteries, that feed blood to the heart muscle, leading to heart attacks. The drug-coated balloon is a medical device used in the treatment of coronary artery disease. The drug is released into the artery during the procedure to help prevent restenosis, which is the re-narrowing of the artery after angioplasty. For instance, in May 2023, according to the report published by the Centers for Disease Control and Prevention, a US-based national public health agency, the coronary heart disease, in United States, increased to 375,476 deaths in 2021 and about 1 in 20 adults aged 20 and older have coronary heart disease. Thus, the rise in the prevalence of coronary artery disease is expected to boost the drug-coated balloon market.

Key Industry Players

Major companies operating in the drug-coated balloons market report are Acotec Scientific AG, AR Baltic Medical AB, B. Braun Melsungen AG, Becton Dickinson and Company, Biosensors International Group Ltd, Medtronic Inc., Koninklijke Philips N.V, Boston Scientific Corporation, Opto Circuits, Acrostak Corp., BioMed, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, RD Global-Invamed, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

The drug-coated balloons  market report table of contents includes:
1. Executive Summary

  1. Market Characteristics
  2. Market Trends And Strategies
  3. Impact Of COVID-19
  4. Market Size And Growth
  5. Segmentation
  6. Regional And Country Analysis

……….

  1. Competitive Landscape And Company Profiles
  2. Key Mergers And Acquisitions
  3. Future Outlook and Potential Analysis

    Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model